Animal Dosing Vehicle Selection

Multidisciplinary Skills & Deep Understanding

Choosing the optimal vehicle for animal PK and Tox studies requires controlling solid and solution variability to yield consistent, coherent data.

Consistency by Design

Ensuring High-Quality PK Data

Crystal Form Control

Ensuring the precise crystal form of the dosed API.

Particle Attributes

Rigorous control of dosed API particle characteristics.

Vehicle Stability

Chemical and physical stability within the chosen vehicle.

Eliminating In-Vivo Guesswork

Programs driven entirely by guesswork are prone to backtracking. We ensure quality data through rigorous evaluation:

Gavageability and the propensity for aggregation.
Biorelevant dissolution behavior throughout the GI tract.
Integrated understanding of compound physical properties.

Coherent PK Data Generation

Achieve Your Success with Our Expertise

Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.  

Our capabilities span three specialized platforms:

Small Molecule
Crystal Bio Solutions
Crystal NAX

By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.

Related Resources

Whitepaper

ADME Simulations: Insights into Bioavailability and Pharmacokinetics

10 Jul 2024



Whitepaper

Optimal Preclinical Formulation Development

14 Jul 2022



Case Study

Parameter Sensitivity with GastroPlus

10 Jul 2024



Small Molecule

First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply

Crystal Bio Solutions

Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)

Crystal NAX

DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products

Platforms

Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet

Quick Links

Highlights News Events Knowledge Hub Webinar Series

 bd_global@crystalpharmatech.com  (925) 558-5040



U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566

Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1

China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Sitemap